Show simple item record

dc.contributor.authorHendry, Jolyon Hen
dc.contributor.authorWest, Catharine M Len
dc.contributor.authorMoore, James Ven
dc.contributor.authorPotten, Christopher Sen
dc.date.accessioned2010-04-09T08:49:59Z
dc.date.available2010-04-09T08:49:59Z
dc.date.issued1994-01
dc.identifier.citationTumour stem cells: the relevance of predictive assays for tumour control after radiotherapy. 1994, 30 (1):11-6 Radiother Oncolen
dc.identifier.issn0167-8140
dc.identifier.pmid8153375
dc.identifier.doi10.1016/0167-8140(94)90004-3
dc.identifier.urihttp://hdl.handle.net/10541/96081
dc.language.isoenen
dc.subjectCanceren
dc.subjectCancerous Stem Cellsen
dc.subjectTumour Stem Cell Assayen
dc.subject.meshCell Cycle
dc.subject.meshHumans
dc.subject.meshNeoplasms
dc.subject.meshNeoplastic Stem Cells
dc.subject.meshPredictive Value of Tests
dc.subject.meshPrognosis
dc.subject.meshRadiation Tolerance
dc.subject.meshTumor Stem Cell Assay
dc.titleTumour stem cells: the relevance of predictive assays for tumour control after radiotherapy.en
dc.typeArticleen
dc.contributor.departmentDepartment of Experimental Radiation Oncology, Paterson Institute for Cancer Research, Christie Hospital (NHS) Trust, Manchester, UK.en
dc.identifier.journalRadiotherapy and Oncologyen


Files in this item

This item appears in the following Collection(s)

Show simple item record